– If approved by the European Commission (EC), the label for EPIDYOLEX® will expand to include a third indication in Europe – – If approved by the European Commission (EC), the label for EPIDYOLEX® will expand to include a third indication in Europe –

Read more:
GW Pharmaceuticals receives positive CHMP opinion for EPIDYOLEX® (cannabidiol) for use as treatment of seizures associated with Tuberous Sclerosis...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh